Two Paradoxes in the Theory of Capital Investment and Competition
This paper considers two paradoxes concerning the relationship between capital investment decisions and competition. First, conventional capital budgeting methods imply that substantial infra-marginal surpluses are attained above the cost of capital, but this is inconsistent with the premise that returns on capital equal the cost of capital in competitive markets. Second, contrasts in the pharmaceutical industry between high reported returns on capital invested, the accounting treatment of research and development outlays, and inter-firm competition in research and development are explored.
Year of publication: |
2013-09
|
---|---|
Authors: | Scherer, F. M. |
Institutions: | Kennedy School of Government, Harvard University |
Saved in:
freely available
Saved in favorites
Similar items by person
-
Mergers and Innovation in the Pharmaceutical Market
Comanor, William S., (2011)
-
Patents, Monopoly Power, and the Pricing of Pharmaceuticals in Low-Income Nations
Scherer, F. M., (2013)
-
Financial Mergers and Their Consequences
Scherer, F. M., (2013)
- More ...